Tag Archives: Pharmaceutical
Cartoon – Drug Shows Great Promise
How Government Policy Promotes High Drug Prices
AHA furious over ruling to exclude ‘orphan’ drugs from 340B program
The ruling means pharmaceutical companies that make orphan drugs do not have to sell then to rural and cancer hospitals at a discount.
Moving Beyond Price-Per-Dose In The Pharmaceutical Industry
Drug Goes From $13.50 a Tablet to $750, Overnight
Brookdale Senior Living among 6 healthcare takeover targets, Goldman Sachs says
Goldman Sachs said the firm expects the demand for senior living centers to grow.
Price of Addiction: Oregon AG outlines drug-maker’s use of aggressive tactics to win over doctors
Behind the $1.1 million settlement between Oregon Attorney General Ellen Rosenblum and a drug manufacturer lies a tale of “unconscionable, false and deceptive sales tactics,” including wining and dining, and even flirting with, Oregon doctors.
Overland Park-based Teva’s parent plans $40.5B deal
Teva Neuroscience Inc.’s parent company plans to acquire the generics unit ofAllergan for $40.5 billion, a deal that will vault Teva Pharmaceutical Industries Ltd. into the top ranks of global drug manufacturers, The Wall Street Journalreports.
Generic drugs pose specific problems for healthcare providers
Rebounding from a tough couple of years due to lack of availability of generic drugs, many healthcare facilities are weighing their options.
HENRY KOTULA 